OncoSeer Diagnostics, Inc. has been selected for the October 2026 Mayo Clinic Platform_Accelerate cohort, joining 30 other digital health companies. OncoSeer aims to help oncologists make better-informed treatment decisions, expand patient access to lifesaving immunotherapies, and reduce treatment discontinuations caused by serious immune-related toxicities.
